Sells FDA-cleared blood pressure monitors whose data feeds directly into hospital software systems like Epic and Cerner.
What stands out
- Earnings significantly exceed cash generation
- Valued far above the size of its business
Sells FDA-cleared blood pressure monitors whose data feeds directly into hospital software systems like Epic and Cerner.
Andon Health makes blood pressure monitors whose cuff inflation algorithm and pressure sensor calibration are legally fixed at the point of FDA 510(k) clearance, and then builds HL7 FHIR data pipelines from that locked hardware configuration into Epic and Cerner's electronic health record systems. Because the hardware cannot change without restarting an 18-month clinical validation cycle, the API integrations that telehealth platforms and Medicare Advantage programs rely on sit on top of a stable, regulatory-anchored data source that a competitor with a newer device cannot replicate without running that same clearance history from scratch. Healthcare providers who have already wired Epic MyChart or Cerner HealtheLife to accept this device's data stream would have to rebuild those integrations for any replacement, and Medicare Advantage plans would have to run their own vendor validation on top of that — so the switching cost compounds on both the software and the institutional side. The weakest point in the whole structure is that if Epic or Cerner updates its FHIR standard in a way that touches how the device encodes readings, fixing the software requires fixing the hardware, which requires a new 510(k), leaving the existing installed base transmitting data that EHR systems will no longer accept for up to 18 months.
How does this company make money?
The company earns money each time a blood pressure monitor or thermometer is sold — either through CVS, Walgreens, and other retail pharmacy chains, or directly to consumers online. On top of that, it charges healthcare systems a recurring software licensing fee for API access that lets those systems pull patient blood pressure readings directly into their records.
What makes this company hard to replace?
Healthcare providers would have to reconfigure Epic MyChart and Cerner HealtheLife patient portals to accept data from a different device's API — that is not a quick settings change. Medicare Advantage plans would have to put any replacement device through their own remote patient monitoring vendor validation process before it could be used in their programs. Individual patients would have to re-pair a new device over Bluetooth and rebuild a baseline of calibrated readings, losing their historical data continuity.
What limits this company?
The company can only release roughly one meaningfully updated device every 12 to 18 months, because every significant change to the inflation algorithm or pressure sensor triggers a full FDA clinical validation cycle that must be built from scratch — it cannot be outsourced or sped up with more money or more engineers.
What does this company depend on?
The company cannot operate without FDA 510(k) clearances for its blood pressure monitors and thermometers, ISO 13485 certified manufacturing facilities, precision pressure transducers from specialized medical component suppliers, Bluetooth Low Energy chipsets for smartphone connectivity, and biocompatible ABS plastics that meet USP Class VI standards.
Who depends on this company?
CVS Pharmacy and Walgreens rely on it to stock their pharmacy sections with home blood pressure monitors — losing the product would leave a gap on those shelves. Teladoc and similar telehealth platforms depend on its devices for the at-home vital sign data streams that feed remote appointments. Medicare Advantage plans use it to run hypertension management programs for patients monitored at home; without it, those programs would lose their device supply.
How does this company scale?
The smartphone app and the blood pressure calculation software can be copied to additional users at almost no extra cost — that part scales easily. What does not scale is FDA approval: every new product variant requires the company to run its own clinical testing and build its own documentation from the ground up, which takes the same 12 to 18 months no matter how large the company grows.
What external forces can significantly affect this company?
Medicare reimbursement policy is the biggest external lever — if the government cuts what it pays for remote patient monitoring, healthcare providers would have far less reason to buy connected blood pressure monitors. U.S.-China trade tariffs on electronic components raise the cost of the Bluetooth chipsets and other parts that go into each device. On the positive side, the aging Baby Boomer generation is driving more demand for home health monitoring, which expands the market the company sells into.
Where is this company structurally vulnerable?
If Epic or Cerner changes its FHIR data integration standard in a way that requires touching how the device encodes or transmits blood pressure readings — deep enough to affect the cleared algorithm or calibration — the company is stuck on two fronts at once: it must renegotiate the software integration and restart an FDA 510(k) cycle simultaneously. During the up-to-18-month gap, devices already in patients' homes would be sending data that hospital systems no longer accept.
Sign in to view price data.
Sign inScreen for dividend patterns
Find other stocks with similar dividend characteristics in the screener.
As of FY2024 (year ended December 31, 2024). Newer annual figures aren't yet on file.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.
CompanyGraph